Formulation of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine and Kolliphor® RH40 using experimental design

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Formulation of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine and Kolliphor® RH40 using experimental design. / Tran, Thuy; Rades, Thomas; Müllertz, Anette.

In: Asian Journal of Pharmaceutical Sciences, Vol. 13, 2018, p. 536-545.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Tran, T, Rades, T & Müllertz, A 2018, 'Formulation of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine and Kolliphor® RH40 using experimental design', Asian Journal of Pharmaceutical Sciences, vol. 13, pp. 536-545. https://doi.org/10.1016/j.ajps.2017.09.006

APA

Tran, T., Rades, T., & Müllertz, A. (2018). Formulation of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine and Kolliphor® RH40 using experimental design. Asian Journal of Pharmaceutical Sciences, 13, 536-545. https://doi.org/10.1016/j.ajps.2017.09.006

Vancouver

Tran T, Rades T, Müllertz A. Formulation of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine and Kolliphor® RH40 using experimental design. Asian Journal of Pharmaceutical Sciences. 2018;13:536-545. https://doi.org/10.1016/j.ajps.2017.09.006

Author

Tran, Thuy ; Rades, Thomas ; Müllertz, Anette. / Formulation of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine and Kolliphor® RH40 using experimental design. In: Asian Journal of Pharmaceutical Sciences. 2018 ; Vol. 13. pp. 536-545.

Bibtex

@article{d44f937c312f4c63863e7b00db055118,
title = "Formulation of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine and Kolliphor{\circledR} RH40 using experimental design",
abstract = "The development of self-nanoemulsifying drug delivery systems (SNEDDS) to enhance the oral bioavailability of lipophilic drugs is usually based on traditional one-factor-at-a-time approaches. These approaches may be inadequate to analyse the effect of each excipient and their potential interactions on the emulsion droplet size formed when dispersing the SNEDDS in an aqueous environment. The current study investigates the emulsion droplet sizes formed from SNEDDS containing different levels of the natural surfactant monoacyl phosphatidylcholine to reduce the concentration of the synthetic surfactant polyoxyl 40 hydrogenated castor oil (Kolliphor{\circledR} RH40). Monoacyl phosphatidylcholine was used in the form of Lipoid S LPC 80 (LPC, containing approximately 80{\%} monoacyl phosphatidylcholine, 13{\%} phosphatidylcholine and 4{\%} concomitant components). The investigated SNEDDS comprised of long-chain or medium-chain glycerides (40{\%} to 75{\%}), Kolliphor{\circledR} RH40 (5{\%} to 55{\%}), LPC (0 to 40{\%}) and ethanol (0 to 10{\%}). D-optimal design, multiple linear regression, and partial least square regression were used to screen different SNEDDS within the investigated excipient ranges and to analyse the effect of each excipient on the resulting droplet size of the dispersed SNEDDS measured by dynamic light scattering. All investigated formulations formed nano-emulsions with droplet sizes from about 20 to 200 nm. The use of medium-chain glycerides was more likely to result in smaller and more monodisperse droplet sizes compared to the use of long-chain glycerides. Kolliphor{\circledR} RH40 exhibited the most significant effect on reducing the emulsion droplet sizes. Increasing LPC concentration increased the emulsion droplet sizes, possibly because of the reduction of Kolliphor{\circledR} RH40 concentration. A higher concentration of ethanol resulted in an insignificant reduction of the emulsion droplet size. The study provides different ternary diagrams of SNEDDS containing LPC and Kolliphor{\circledR} RH40 as a reference for formulation developers.",
keywords = "Cryogenic transmission electron microscopy, D-optimal design, Droplet size, Monoacyl phosphatidylcholine, Polyoxyl 40 hydrogenated castor oil (Kolliphor RH40), Self-nanoemulsifying drug delivery systems",
author = "Thuy Tran and Thomas Rades and Anette M{\"u}llertz",
year = "2018",
doi = "10.1016/j.ajps.2017.09.006",
language = "English",
volume = "13",
pages = "536--545",
journal = "Asian Journal of Pharmaceutical Sciences",
issn = "1818-0876",
publisher = "Hong Kong Asiamed Publish House",

}

RIS

TY - JOUR

T1 - Formulation of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine and Kolliphor® RH40 using experimental design

AU - Tran, Thuy

AU - Rades, Thomas

AU - Müllertz, Anette

PY - 2018

Y1 - 2018

N2 - The development of self-nanoemulsifying drug delivery systems (SNEDDS) to enhance the oral bioavailability of lipophilic drugs is usually based on traditional one-factor-at-a-time approaches. These approaches may be inadequate to analyse the effect of each excipient and their potential interactions on the emulsion droplet size formed when dispersing the SNEDDS in an aqueous environment. The current study investigates the emulsion droplet sizes formed from SNEDDS containing different levels of the natural surfactant monoacyl phosphatidylcholine to reduce the concentration of the synthetic surfactant polyoxyl 40 hydrogenated castor oil (Kolliphor® RH40). Monoacyl phosphatidylcholine was used in the form of Lipoid S LPC 80 (LPC, containing approximately 80% monoacyl phosphatidylcholine, 13% phosphatidylcholine and 4% concomitant components). The investigated SNEDDS comprised of long-chain or medium-chain glycerides (40% to 75%), Kolliphor® RH40 (5% to 55%), LPC (0 to 40%) and ethanol (0 to 10%). D-optimal design, multiple linear regression, and partial least square regression were used to screen different SNEDDS within the investigated excipient ranges and to analyse the effect of each excipient on the resulting droplet size of the dispersed SNEDDS measured by dynamic light scattering. All investigated formulations formed nano-emulsions with droplet sizes from about 20 to 200 nm. The use of medium-chain glycerides was more likely to result in smaller and more monodisperse droplet sizes compared to the use of long-chain glycerides. Kolliphor® RH40 exhibited the most significant effect on reducing the emulsion droplet sizes. Increasing LPC concentration increased the emulsion droplet sizes, possibly because of the reduction of Kolliphor® RH40 concentration. A higher concentration of ethanol resulted in an insignificant reduction of the emulsion droplet size. The study provides different ternary diagrams of SNEDDS containing LPC and Kolliphor® RH40 as a reference for formulation developers.

AB - The development of self-nanoemulsifying drug delivery systems (SNEDDS) to enhance the oral bioavailability of lipophilic drugs is usually based on traditional one-factor-at-a-time approaches. These approaches may be inadequate to analyse the effect of each excipient and their potential interactions on the emulsion droplet size formed when dispersing the SNEDDS in an aqueous environment. The current study investigates the emulsion droplet sizes formed from SNEDDS containing different levels of the natural surfactant monoacyl phosphatidylcholine to reduce the concentration of the synthetic surfactant polyoxyl 40 hydrogenated castor oil (Kolliphor® RH40). Monoacyl phosphatidylcholine was used in the form of Lipoid S LPC 80 (LPC, containing approximately 80% monoacyl phosphatidylcholine, 13% phosphatidylcholine and 4% concomitant components). The investigated SNEDDS comprised of long-chain or medium-chain glycerides (40% to 75%), Kolliphor® RH40 (5% to 55%), LPC (0 to 40%) and ethanol (0 to 10%). D-optimal design, multiple linear regression, and partial least square regression were used to screen different SNEDDS within the investigated excipient ranges and to analyse the effect of each excipient on the resulting droplet size of the dispersed SNEDDS measured by dynamic light scattering. All investigated formulations formed nano-emulsions with droplet sizes from about 20 to 200 nm. The use of medium-chain glycerides was more likely to result in smaller and more monodisperse droplet sizes compared to the use of long-chain glycerides. Kolliphor® RH40 exhibited the most significant effect on reducing the emulsion droplet sizes. Increasing LPC concentration increased the emulsion droplet sizes, possibly because of the reduction of Kolliphor® RH40 concentration. A higher concentration of ethanol resulted in an insignificant reduction of the emulsion droplet size. The study provides different ternary diagrams of SNEDDS containing LPC and Kolliphor® RH40 as a reference for formulation developers.

KW - Cryogenic transmission electron microscopy

KW - D-optimal design

KW - Droplet size

KW - Monoacyl phosphatidylcholine

KW - Polyoxyl 40 hydrogenated castor oil (Kolliphor RH40)

KW - Self-nanoemulsifying drug delivery systems

U2 - 10.1016/j.ajps.2017.09.006

DO - 10.1016/j.ajps.2017.09.006

M3 - Journal article

AN - SCOPUS:85033587960

VL - 13

SP - 536

EP - 545

JO - Asian Journal of Pharmaceutical Sciences

JF - Asian Journal of Pharmaceutical Sciences

SN - 1818-0876

ER -

ID: 196008179